New Data Highlight Aranesp Efficacy in Anemic Patients with Lymphoid Cancer Read more about New Data Highlight Aranesp Efficacy in Anemic Patients with Lymphoid Cancer
In a New Clinical Study, Enbrel Taken Once Weekly Significantly Reduced Pain and Inflammation and Improved Function in Rheumatoid Arthritis Patients Read more about In a New Clinical Study, Enbrel Taken Once Weekly Significantly Reduced Pain and Inflammation and Improved Function in Rheumatoid Arthritis Patients
Enbrel Provided Rapid and Significant Relief for Psoriasis Patients in Second Pivotal Study Read more about Enbrel Provided Rapid and Significant Relief for Psoriasis Patients in Second Pivotal Study
Enbrel Rapidly and Significantly Improved Back Pain, Mobility and Physical Function in Patients with Ankylosing Spondylitis Read more about Enbrel Rapidly and Significantly Improved Back Pain, Mobility and Physical Function in Patients with Ankylosing Spondylitis
Enbrel Combination Therapy Inhibited Progression of Joint Damage and Offered Significant Rheumatoid Arthritis Symptom Relief in New Clinical Study Read more about Enbrel Combination Therapy Inhibited Progression of Joint Damage and Offered Significant Rheumatoid Arthritis Symptom Relief in New Clinical Study
Enbrel is First Anti-TNF Therapy Submitted to the FDA for Approval to Treat Psoriasis Read more about Enbrel is First Anti-TNF Therapy Submitted to the FDA for Approval to Treat Psoriasis
Enbrel is First Biologic Recommended by FDA Panel for Approval to Treat Ankylosing Spondylitis Read more about Enbrel is First Biologic Recommended by FDA Panel for Approval to Treat Ankylosing Spondylitis
Amgen Announces Webcast of Second Quarter 2003 Read more about Amgen Announces Webcast of Second Quarter 2003
Amgen Names Dr. Willard Dere Vice President, Global Inflammation Clinical Development Read more about Amgen Names Dr. Willard Dere Vice President, Global Inflammation Clinical Development
TEN THOUSAND PATIENTS ENROLLED IN LANDMARK RHEUMATOID ARTHRITIS STUDY PROGRAM Read more about TEN THOUSAND PATIENTS ENROLLED IN LANDMARK RHEUMATOID ARTHRITIS STUDY PROGRAM
